Sage Therapeutics Announces Strategic Reorganization to …
21 hours ago · CAMBRIDGE, Mass., October 17, 2024--Sage Therapeutics, Inc. (Nasdaq: SAGE), today announced a strategic reorganization of its business operations to support the ongoing launch of ZURZUVAE in ...
Sage Cuts One-Third of Workforce After Clinical Trial Setbacks
19 hours ago · 1:23. Sage Therapeutics Inc. is laying off more than 165 employees as the biotech company tries to conserve cash after multiple setbacks to its pipeline. The job cuts will affect about one-third ...
Sage Therapeutics, Inc. (SAGE) - Yahoo Finance
Get the latest Sage Therapeutics, Inc. (SAGE) stock news and headlines to help you in your trading and investing decisions.
Sage Therapeutics Announces Topline Results from the Phase 2
Oct 8, 2024 · Sage Therapeutics, Inc. announced today topline results from LIGHTWAVE, a 12- week, Phase 2 randomized, double-blind, placebo-controlled study to evaluate the effects of dalzanemdor in ...
Biopharmaceutical Company for Brain Health Medicine | Sage Therapeutics
Sage developed the only two FDA-approved treatments indicated for postpartum depression and is advancing a robust pipeline to target unmet needs in brain health. Sage Therapeutics is a biopharmaceutical company developing novel therapies for brain health disorders with Depression, Neurology and Neuropsychiatric franchise programs.
Press Releases - Sage Therapeutics, Inc.
Sage Therapeutics Announces Topline Results from the Phase 2 LIGHTWAVE Study of Dalzanemdor (SAGE-718) in the Treatment of Mild Cognitive Impairment and Mild Dementia in Alzheimer’s Disease.
Investors & Media - Sage Therapeutics, Inc.
Aug 4, 2023 · CAMBRIDGE, Mass. -- (BUSINESS WIRE)--Aug. 4, 2023-- Sage Therapeutics, Inc. (Nasdaq: SAGE) and Biogen Inc. (Nasdaq: BIIB) announced the U.S. Food and Drug Administration (FDA) approved ZURZUVAE TM (zuranolone) 50 mg for adults with postpartum depression (PPD).
Sage Therapeutics Announces Phase 2 SURVEYOR Study …
Jun 11, 2024 · Sage Therapeutics (Nasdaq: SAGE) is a biopharmaceutical company committed to our mission of pioneering solutions to deliver life-changing brain health medicines, so every person can thrive. Sage developed the only two FDA-approved treatments indicated for postpartum depression and is advancing a robust pipeline to target unmet needs in brain ...
Sage Therapeutics, Inc. (SAGE) Stock Price, News, Quote
Find the latest Sage Therapeutics, Inc. (SAGE) stock quote, history, news and other vital information to help you with your stock trading and investing.
Sage Therapeutics to lay off one-third staff under reorganization
1 day ago · Oct. 17, 2024 8:56 AM ETSage Therapeutics, Inc. (SAGE) StockBy: Nilanjana Basu, SA News Editor. Play(1min) Klaus Vedfelt. Sage Therapeutics (NASDAQ:SAGE) announced a reorganization, including a ...